Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects.

Author: AokiIkuo, AsoMasako, IshikawaKensuke, WakanaAkira, YoshinariTomoko

Paper Details 
Original Abstract of the Article :
This was a phase I double-blind, randomized, placebo-controlled, 2-period, single-dose, crossover study in healthy Japanese subjects to evaluate the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin. Twenty healthy subjects were randomized; 16 received a single int...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jiac.2014.11.001

データ提供:米国国立医学図書館(NLM)

Daptomycin: A New Antibiotic for Japanese Patients

This research delves into the safety, tolerability, and pharmacokinetics of daptomycin in healthy Japanese subjects, exploring the potential of this antibiotic for treating infections in this population. It's like conducting a scientific expedition into a new desert, exploring the effects of a new drug on a specific group of people. The research aims to determine if daptomycin is safe and effective for Japanese patients, paving the way for its potential use in treating infections.

Addressing Safety and Efficacy

The study examines the safety, tolerability, and pharmacokinetic profile of daptomycin in Japanese subjects. It's like testing the waters of a new oasis, ensuring that they are safe and refreshing for the inhabitants. This research provides valuable insights into the drug's potential use in Japanese patients, ensuring that it is safe and effective for this population.

Expanding Treatment Options

This research highlights the importance of studying the effects of medications in different populations, ensuring that treatment options are safe and effective for all. It's a reminder that the desert of drug development is vast and diverse, requiring careful exploration and testing to ensure the best outcomes for all. This research provides valuable data for clinicians in Japan, expanding their treatment options for patients with bacterial infections.

Dr.Camel's Conclusion

This research is a testament to the ongoing efforts to develop new and effective therapies for treating infections. It's a reminder that the journey to better health is a continuous one, requiring careful consideration of individual needs and diverse populations. This research is a beacon of knowledge, guiding us towards a more inclusive and effective approach to treating infections worldwide.
Date :
  1. Date Completed 2015-10-29
  2. Date Revised 2015-02-09
Further Info :

Pubmed ID

25572140

DOI: Digital Object Identifier

10.1016/j.jiac.2014.11.001

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.